Abstract Background Anogenital warts (AGWs) caused by the human papillomavirus (HPV)
are a common manifestation of HPV infection. Treatment strategies generally include topical …

Human papillomavirus (HPV) is the most prevalent sexually transmitted infection worldwide
and ano-genital warts (AGWs) are highly infectious. This virus is transmitted through sexual …

Human papillomavirus (HPV) vaccines are preventive measures to decrease HPV infection
rates. Knowledge of their efficacy as treatment options for anogenital warts (AGWs) and oral …

Background Although new HPV vaccines have been developed and are in the process of
implementation, anogenital warts remain a very frequent problem in clinical practice …

Objective: To review evidence on the efficacy of HPV vaccines in the prevention of non-
cancer lesions (anogenital warts [AGW], recurrent laryngeal papillomatosis and oral …

In line with previous case-reports, the study conducted by Hoom Choi ascertained the
effectiveness of the HPV vaccine as a promising approach in the therapeutic management of …

2011 European Guideline for the Management of Anogenital Warts CJN Lacey1, SC
Woodhall1, A Wikstrom2 and J Ross3 1Hull York M Page 1 IUSTI 2011 GW guidelines V7 …

Anogenital warts (AGWs) rank among the most frequent sexually transmitted infections in
young adults. They are benign lesions, but they pose a significant economic cost to health …

Abstract Treatment of anogenital warts (AGWs) is challenging. Candida antigen
immunotherapy has been proven to be a safe and relatively effective therapeutic modality; …

Background Assessing the impact and effectiveness of HPV vaccines on anogenital warts in
the United States can provide early indication of the success of vaccination programs as well …